Rheumatoid arthritis (RA) is the leading indication, accounting for approximately 36% of the total market value, or USD 35.7 ...

General Upendra Dwivedi states the Army is ready to induct women in infantry pending societal acceptance, emphasizing gender ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a ...

The Serby Mock 1.0 gives head coach Aaron Glenn and GM Darren Mougey their quarterback of the future, plus a pair of picks, ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

Patients with rheumatoid arthritis (RA) who receive immune checkpoint inhibitor (ICI) therapy for cancer do not appear to face higher mortality compared against patients without RA receiving the same ...

Positive full results from the Phase III TULIP-SC trial showed the subcutaneous administration of Saphnelo demonstrated a statistically ...

Saphnelo IV infusion is approved for the treatment of moderate to severe SLE in more than 70 countries worldwide including the US, EU and Japan, with regulatory reviews ongoing in other countries ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera's Infusion Specialty Therapies Business Unit (IST). This strategic acq ...

Use of TNF inhibitors during pregnancy and postpartum was not associated with a significantly increased risk for serious infection, but exposed pregnancies had numerically higher rates of infection.